| Product Information |
|
| Registration Number |
DR-XY45929 (for DOH Use Only)
|
| Generic Name |
Lamivudine + Tenofovir disoproxil fumarate
|
| Brand Name |
None
|
| Dosage Strength |
300 mg/ 300 mg
|
| Dosage Form |
Film-Coated Tablet
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
Nucleoside and Nucleotide Reverse Transcriptase
Inhibitor Combination
|
| Packaging |
White opaque HDPE bottle with white opaque continuous threading plastic cap x 30 tablets (box of 30 tablets)
|
| Manufacturer |
Hetero Labs Limited (Unit III)
|
| Country of Origin |
India
|
| Trader |
N/A
|
| Importer |
Camber Pharmaceuticals, Inc.
|
| Distributor |
Camber Pharmaceuticals, Inc.
|
| Application Type |
Initial (from Monitored Release)
|
| Issuance Date |
26 October 2022
|
| Expiry Date |
06 June 2027
|